½ÃÀ庸°í¼­
»óǰÄÚµå
1505218

¼¼°èÀÇ ½ÉÀå ¸ÅÇÎ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global Cardiac Mapping Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 174 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ½ÉÀå ¸ÅÇÎ ½ÃÀå ¼ö¿ä´Â 2023³â 35¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2032³â¿¡´Â 61¾ï 7,000¸¸ ´Þ·¯ ±Ùó ½ÃÀå ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ 2024³âºÎÅÍ 2032³â±îÁö CAGRÀº 6.31%·Î Àü¸ÁµË´Ï´Ù.

½ÉÀå ¸ÅÇÎÀº ½ÉÀå ³» Àü±â Ȱµ¿ÀÇ »ó¼¼ÇÑ ¸ÊÀ» ¸¸µå´Â µ¥ »ç¿ëµÇ´Â Áø´Ü ÀýÂ÷ÀÔ´Ï´Ù. ÀÌ ±â¼úÀº ºñÁ¤»óÀûÀÎ ½ÉÀå ¸®µë°ú ºÎÁ¤¸ÆÀÇ ¿øÀÎÀ» È®ÀÎÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ ÀýÂ÷¿¡¼­´Â ½ÉÀå ³»ºÎ ¶Ç´Â Ç¥¸é¿¡ Àü±ØÀ» ¼³Ä¡ÇÏ¿© Àü±â ½ÅÈ£¸¦ ±â·ÏÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½ÅÈ£´Â ºÐ¼®µÇ°í ½Ã°¢È­µÇ¹Ç·Î ÀÇ»ç´Â ºÎÁ¤¸ÆÀ» ÀÏÀ¸Å°´Â ºÎÀ§¸¦ ÇÉ Æ÷ÀÎÆ®·Î È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ °Ë»ç´Â Ä«Å×ÅÍ ÀýÁ¦¸¦ Æ÷ÇÔÇÑ ºÎÁ¤¸Æ Ä¡·á ÁöħÀ¸·Î ÇʼöÀûÀÔ´Ï´Ù. °³ÀÔÀÇ È¿´ÉÀ» ³ôÀÌ´Â Á¤È®ÇÑ Á¤º¸¸¦ Á¦°øÇÏ¿© ½ÉÀå ¸®µë Àå¾Ö °ü¸®¿¡¼­ ȯÀÚ °á°ú¸¦ °³¼±ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

½ÉÀå ºÎÁ¤¸Æ ¹× ±âŸ ½ÉÀå °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÁÖ·Î ½ÉÀå ¸ÅÇÎ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ½ÉÀå Áúȯ¿¡ °É¸®±â ½¬¿î ³ëÀÎ Àα¸ Áõ°¡´Â ½ÉÀå ¸ÅÇΰú °°Àº °í±Þ Áø´Ü µµ±¸ ¼ö¿ä¿¡ Å©°Ô ±â¿©ÇÕ´Ï´Ù. °íÇØ»óµµ·Î ½Ç½Ã°£ ¿µ»ó ±â¼úÀ» °³¹ßÇÏ´Â µî ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛÀÇ ±â¼úÀû Áøº¸·Î Áø´Ü Á¤È®µµ¿Í Ä¡·á ¼ºÀûÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ³·Àº ħ½À ÀýÂ÷ÀÇ »ç¿ë Áõ°¡, Á¶±â Áø´Ü ¹× °³ÀÔÀÇ ÀÌÁ¡¿¡ ´ëÇÑ Àνĵµ ÁÖ¿ä ÃËÁø¿äÀÎÀÌ µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ °Ç°­ °ü¸® ÀÎÇÁ¶ó¿¡ ´ëÇÑ ¸¹Àº ÅõÀÚ¿Í ¸ÂÃãÇü ÀÇ·áÀÇ Á߿伺ÀÌ Ä¿Áü¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ±â¼úÀÇ ³ôÀº ºñ¿ë°ú Àü¹®ÀûÀÎ ÀÇ·á Áö½ÄÀÇ Çʿ伺Àº ¾ÕÀ¸·Î ¼ö³â°£ ½ÃÀå ¼ºÀåÀÇ °úÁ¦°¡ µÉ ¼ö ÀÖ½À´Ï´Ù.

Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Â ºÐ¼® ¹× ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØÀÇ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ¼¼°èÀÇ ½ÉÀå ¸ÅÇÎ ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÉÀå ¸ÅÇÎ »ê¾÷ÀÇ ¼ºÀå°ú Ãß¼¼´Â ÀÌ ¿¬±¸¿¡ Àü¹ÝÀûÀÎ Á¢±ÙÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

½ÉÀå ¸ÅÇÎ ½ÃÀå Á¶»ç º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡º° ¹× Áö¿ªº° ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·«°¡°¡ °¢ Á¦Ç° ¶Ç´Â ¼­ºñ½ºÀÇ Å¸°Ù °èÃþÀ» ÆÄ¾ÇÇÒ ¶§ ÇâÈÄ ±âȸ¸¦ Áö¿øÇÕ´Ï´Ù.

Á¦Ç° À¯Çüº°

  • ºñÁ¢ÃËÇü ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ
  • Á¢ÃËÇü ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ

ÀûÀÀ Áúȯº°

  • ½É¹æ¼¼µ¿
  • ½É¹æ Á¶µ¿
  • ¹æ½Ç °áÀý ÀçÀÔ °¡´É¼º ºó¹Ú(AVNRT)

ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ½ÉÀå¼¾ÅÍ
  • ±âŸ(Á¶»ç±â°ü µî)

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ ½ÉÀå ¸ÅÇÎ ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ Àú¸íÇÑ ¸ðµç Áö¿ª¿¡¼­ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

¸ÂÃ㠿䱸»çÇ×ÀÌ ÀÖ´Â °æ¿ì Google¿¡ ¹®ÀÇÇϼ¼¿ä. ´ç»çÀÇ ¼³¹®Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå ½ÉÀå ¸ÅÇÎ-»ê¾÷ ºÐ¼®

  • ¼­¹® : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ±¸¸ÅÀÚ ¸ñ·Ï
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ½ÉÀå ¸ÅÇÎ ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°

  • °³¿ä : Á¦Ç° À¯Çüº°
  • °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : Á¦Ç° À¯Çüº°
  • ºñÁ¢ÃËÇü ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ
  • Á¢ÃËÇü ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ

Á¦6Àå ¼¼°èÀÇ ½ÉÀå ¸ÅÇÎ ½ÃÀå ºÐ¼® : ÀûÀÀ Áúȯº°

  • °³¿ä : ÀûÀÀ Áúȯº°
  • °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : ÀûÀÀ Áúȯº°
  • ½É¹æ¼¼µ¿
  • ½É¹æ Á¶µ¿
  • ¹æ½Ç °áÀý ÀçÀÔ °¡´É¼º ºó¹Ú(AVNRT)

Á¦7Àå ¼¼°èÀÇ ½ÉÀå ¸ÅÇÎ ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÃÖÁ¾ »ç¿ëÀÚº° °³¿ä
  • ÃÖÁ¾ »ç¿ëÀÚº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ½ÉÀå¼¾ÅÍ
  • ±âŸ(¿¬±¸±â°ü µî)

Á¦8Àå ¼¼°èÀÇ ½ÉÀå ¸ÅÇÎ ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­¹®
  • ºÏ¹ÌÀÇ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ½ÉÀå ¸ÅÇÎ ±â¾÷°æÀï ±¸µµ

  • ½ÉÀå ¸ÅÇÎ ½ÃÀå °æÀï
  • Á¦ÈÞ, Çù·Â ¹× ÇÕÀÇ
  • ÇÕº´ ¹× Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Abbott Laboratories
  • Acutus Medical Inc.
  • Koninklijke Philips NV
  • Johnson & Johnson Services Inc.
  • Boston Scientific Corporation
  • Lepu Medical Technology(Beijing) Co. Ltd.
  • Medtronic
  • MicroPort Scientific Corporation
  • APN Health LLC
  • AngioDynamics
AJY 24.07.11

The global demand for Cardiac Mapping Market is presumed to reach the market size of nearly USD 6.17 Billion by 2032 from USD 3.56 Billion in 2023 with a CAGR of 6.31% under the study period 2024-2032.

Cardiac mapping is a diagnostic procedure used to create detailed maps of the electrical activity within the heart. This technique helps identify the origins of abnormal heart rhythms or arrhythmias. During this procedure, electrodes are placed inside or on the surface of the heart to record electrical signals. These signals are then analyzed and visualized, allowing physicians to pinpoint areas causing irregular heartbeats. It is essential in guiding the treatment of arrhythmias, including catheter ablation procedures. It provides precise information that enhances the effectiveness of interventions, improving patient outcomes in managing heart rhythm disorders.

MARKET DYNAMICS

The increasing prevalence of cardiac arrhythmias and other heart-related disorders primarily drives the cardiac mapping market. The growing aging population, more susceptible to heart diseases, significantly contributes to the demand for advanced diagnostic tools like cardiac mapping. Technological advancements in cardiac mapping systems, including developing high-resolution and real-time imaging techniques, have greatly enhanced diagnostic accuracy and treatment outcomes. The increasing use of minimally invasive procedures and awareness of early diagnosis and intervention benefits are also key drivers. Furthermore, substantial investments in healthcare infrastructure and the growing emphasis on personalized medicine propel market growth. However, the high cost of technology and the need for specialized medical expertise may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cardiac Mapping. The growth and trends of Cardiac Mapping industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cardiac Mapping market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Non-contact Cardiac Mapping Systems
  • Contact Cardiac Mapping Systems

By Disease Indication

  • Atrial Fibrillation
  • Arial Flutter
  • Atrioventricular Nodal Re-Entry Tachycardia (AVNRT)

By End-user

  • Hospitals
  • Specialty Clinics
  • Cardiac Centers
  • Others (Research Institutes, etc.)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiac Mapping market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiac Mapping market include Abbott Laboratories, Acutus Medical Inc., Koninklijke Philips N.V., Johnson & Johnson Services Inc., Boston Scientific Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Medtronic, MicroPort Scientific Corporation, APN Health LLC, AngioDynamics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CARDIAC MAPPING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Disease Indication
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CARDIAC MAPPING MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Non-contact Cardiac Mapping Systems Historic and Forecast Sales By Regions
  • 5.4. Contact Cardiac Mapping Systems Historic and Forecast Sales By Regions

6. GLOBAL CARDIAC MAPPING MARKET ANALYSIS BY DISEASE INDICATION

  • 6.1. Overview By Disease Indication
  • 6.2. Historical and Forecast Data Analysis By Disease Indication
  • 6.3. Atrial Fibrillation Historic and Forecast Sales By Regions
  • 6.4. Arial Flutter Historic and Forecast Sales By Regions
  • 6.5. Atrioventricular Nodal Re-Entry Tachycardia (AVNRT) Historic and Forecast Sales By Regions

7. GLOBAL CARDIAC MAPPING MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data Analysis By End-user
  • 7.3. Hospitals Historic and Forecast Sales By Regions
  • 7.4. Specialty Clinics Historic and Forecast Sales By Regions
  • 7.5. Cardiac Centers Historic and Forecast Sales By Regions
  • 7.6. Others (Research Institutes, etc.) Historic and Forecast Sales By Regions

8. GLOBAL CARDIAC MAPPING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CARDIAC MAPPING COMPANIES

  • 9.1. Cardiac Mapping Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF CARDIAC MAPPING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott Laboratories
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Acutus Medical Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Koninklijke Philips N.V.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Johnson & Johnson Services Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Boston Scientific Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Lepu Medical Technology (Beijing) Co. Ltd.
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Medtronic
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. MicroPort Scientific Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. APN Health LLC
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. AngioDynamics
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦